After Acticon Approval, AMS Looks To Biodegradable Stent For BPH
This article was originally published in The Gray Sheet
Executive Summary
American Medical Systems, following the Dec. 18 PMA approval of its Acticon neosphincter for severe fecal incontinence, says it will focus development efforts going forward on the BioFlow biodegradable stent for benign prostatic hyperplasia
You may also be interested in...
Curon’s Secca System For Fecal Incontinence Receives 510(k) Clearance
Curon Medical's 12 sales reps will market the Secca system for the treatment of fecal incontinence. FDA 510(k) clearance was announced March 25
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”